about
Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr miceA novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritisChemokines in systemic lupus erythematosus involving the central nervous system.Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjögren's syndrome.Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis.Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.A case of rheumatoid arthritis with bucillamine-induced yellow nail syndrome initially manifesting as pulmonary disease.Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment.Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate.Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study.Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study.A novel approach of understanding prediction models: TRIPOD framework.A case of Degos disease: demonstration of C5b-9-mediated vascular injury.Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.Activated leucocytes express and secrete macrophage inflammatory protein-1alpha upon interaction with synovial fibroblasts of rheumatoid arthritis via a beta2-integrin/ICAM-1 mechanismExpression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)Interaction of monocytes with vascular endothelial cells synergistically induces interferon gamma-inducible protein 10 expression through activation of specific cell surface molecules and cytokinesHigher maximal serum concentration of methotrexate predicts the incidence of adverse reactions in Japanese rheumatoid arthritis patientsElevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestationsSynergistic induction of CX3CL1 by interleukin-1β and interferon-γ in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathwaysCorrelation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndromeElevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activityRelationship between psychological factors and arthralgia in patients with rheumatoid arthritisAge and quality of life in patients with rheumatoid arthritis treated with biologic agentsSerum anti-Müllerian hormone levels in women with rheumatoid arthritis during tumor necrosis factor-α inhibitor treatment: Exploratory researchThe development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness methodFragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activityDamage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registrySalt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study
P50
Q24793184-E62CDC3C-D07B-4497-BF19-1B4E8780CFD7Q24804035-0CAB6594-DDA0-4297-A8A4-1859C128E356Q36992490-BF466BC7-AB20-40A4-9C61-1A9A9DC8C356Q37358089-71F10300-B103-4A41-B6B1-36066849E8E4Q39319897-6CFDF310-38C7-433E-8EFC-A2B69450A70BQ41534957-3C7B63D6-6FA5-4B76-B1D8-81A087239AFFQ42452223-2949ABE1-88A7-48DE-9807-4C9F900F421AQ42637719-3871B137-579E-48B2-85D1-F7FAC4AD0381Q43048905-8FA3F31C-531A-472E-9BE0-A78BBAAD965EQ46013134-87A77012-2EDC-4365-B810-0DA319F4EBCAQ50099510-4A242CC5-DD86-4C31-BB82-9F2FCEAE0334Q51682328-70A9B61F-F3A5-4249-BB7B-A3D3630C03FCQ52741617-1D1CFC57-4C46-456B-8D4C-7FE4C61E5530Q53067580-443E2FE5-0C4D-4F1E-B2AA-2D34D61007A7Q54573513-6AE979AB-3FDA-4C2E-80A9-E36B11A42D3AQ73588003-D30CD645-FAE6-4472-B8B9-4AD3B28BA718Q74261271-2A0DF05F-9CF6-4DAB-AAE9-A3F69164484DQ78951915-D1ADF684-BA5B-42C1-B2FD-DBD8ED467A85Q80786309-C29F1742-6723-4CF2-9D22-A254FE4AFA9FQ81811376-03482ACE-25D0-4194-A0B7-2743A6CC9B3BQ83265995-180397F5-566D-4A6A-A8FB-323C3B8B2123Q83417185-50408E67-CC3A-4F42-9235-0A5519720297Q84183567-95E63A0B-BB95-41F2-8BE2-29723E37E3B1Q87023538-2B8EDEC7-AAA5-4CED-A228-C605A68F463BQ90862471-AEA4DE5C-2000-400E-ADED-74780F36C9D2Q92099632-F8E49C6B-D275-4CC9-96A2-BB1920073405Q92183219-E529CDD1-EB18-4095-95E2-91DBC89B8DCBQ92375497-3E63C776-0B9B-4B5C-A416-4F1FEC1A9A7EQ92559280-87859155-9201-404A-91BD-5BC096F3747CQ93056850-40C031CA-86BC-4A87-9128-3BF12E8DFE3F
P50
description
researcher
@en
name
Nobuyuki Yajima
@en
Nobuyuki Yajima
@nl
type
label
Nobuyuki Yajima
@en
Nobuyuki Yajima
@nl
prefLabel
Nobuyuki Yajima
@en
Nobuyuki Yajima
@nl
P106
P31
P496
0000-0002-8292-3962